Literature DB >> 25974364

Day Hospital Treatment for Anorexia Nervosa: A 12-Month Follow-up Study.

Giovanni Abbate-Daga1, Enrica Marzola1, Carlotta De-Bacco1, Sara Buzzichelli1, Annalisa Brustolin1, Stefania Campisi1, Federico Amianto1, Giuseppe Migliaretti2, Secondo Fassino1.   

Abstract

Day hospitals (DHs) represent a treatment option for anorexia nervosa (AN), a mental disorder that is difficult to treat and has no evidence-based treatments available. We aimed to determine the effectiveness of a DH treatment that was specifically focused on the emotions of severe AN patients. Body mass index and eating psychopathology were the primary outcome measures. Fifty-six adult patients with AN were assessed upon admission, at the end of treatment (EOT) and at a 12-month follow-up evaluation (T18) using Eating Disorders Inventory-2, Beck Depression Inventory, Hamilton Rating Scale for Anxiety and Brief Social Phobia Scale. All participants received a multidisciplinary treatment programme that focused on psychodynamic psychotherapy. Seventy-eight per cent of participants reported positive outcomes at EOT and 68% at T18. Moreover, 82.1% and 65.4% of long-standing patients showed positive outcomes at EOT and T18, respectively. All measures of psychopathology were significantly improved at EOT and were maintained at follow-up. Our DH was effective at treating severe AN patients; however, further investigations of the processes of change are warranted.
Copyright © 2015 John Wiley & Sons, Ltd and Eating Disorders Association.

Entities:  

Keywords:  anorexia nervosa; day hospital; eating disorders; outcome

Mesh:

Year:  2015        PMID: 25974364     DOI: 10.1002/erv.2369

Source DB:  PubMed          Journal:  Eur Eat Disord Rev        ISSN: 1072-4133


  8 in total

1.  Depression, worry, and psychosocial functioning predict eating disorder treatment outcomes in a residential and partial hospitalization setting.

Authors:  Laura K Fewell; Cheri A Levinson; Lynn Stark
Journal:  Eat Weight Disord       Date:  2017-03-07       Impact factor: 4.652

2.  Combining day treatment and outpatient treatment for eating disorders: findings from a naturalistic setting.

Authors:  Ina Beintner; Kristian Hütter; Katrin Gramatke; Corinna Jacobi
Journal:  Eat Weight Disord       Date:  2019-01-31       Impact factor: 4.652

3.  Virtual Online Home-Based Treatment During the COVID-19 Pandemic for Ultra-Orthodox Young Women With Eating Disorders.

Authors:  Yael Latzer; Esther Herman; Rahel Ashkenazi; Orna Atias; Sofia Laufer; Ateret Biran Ovadia; Tova Oppenheim; Meirv Shimoni; Moria Uziel; Daniel Stein
Journal:  Front Psychiatry       Date:  2021-05-24       Impact factor: 4.157

4.  Treatment of eating disorders in adolescents during the COVID-19 pandemic: a case series.

Authors:  Serur Yaffa; Enoch-Levy Adi; Pessach Itai; Joffe-Milstein Marit; Gothelf Doron; Stein Daniel
Journal:  J Eat Disord       Date:  2021-02-10

5.  Effectiveness of integrated treatment for eating disorders in Spain: protocol for a multicentre, naturalistic, observational study.

Authors:  Antoni Grau Touriño; Guillem Feixas; Joan Carles Medina; Clara Paz; Chris Evans
Journal:  BMJ Open       Date:  2021-03-08       Impact factor: 2.692

6.  Treatment response in children and adolescents with anorexia nervosa: a naturalistic, case-control study.

Authors:  Jacopo Pruccoli; Ilaria Pettenuzzo; Antonia Parmeggiani
Journal:  Eat Weight Disord       Date:  2022-06-15       Impact factor: 3.008

Review 7.  Psychotherapeutic Treatment for Anorexia Nervosa: A Systematic Review and Network Meta-Analysis.

Authors:  Almut Zeeck; Beate Herpertz-Dahlmann; Hans-Christoph Friederich; Timo Brockmeyer; Gaby Resmark; Ulrich Hagenah; Stefan Ehrlich; Ulrich Cuntz; Stephan Zipfel; Armin Hartmann
Journal:  Front Psychiatry       Date:  2018-05-01       Impact factor: 4.157

8.  Body shape in inpatients with severe anorexia nervosa.

Authors:  Enrica Marzola; Matteo Panero; Fabio Cavallo; Nadia Delsedime; Giovanni Abbate-Daga
Journal:  Eur Psychiatry       Date:  2020-01-31       Impact factor: 5.361

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.